^
BIOMARKER:

FGFR mutation

i
Other names: FGFR, Fibroblast Growth Factor Receptor
Related biomarkers:
FGFR mutation
Urothelial Cancer
erdafitinib
Sensitive: A2 - Guideline
FGFR mutation
Urothelial Cancer
pemigatinib
Sensitive: C2 – Inclusion Criteria
FGFR mutation
Pancreatic Cancer
pemigatinib
Sensitive: C2 – Inclusion Criteria
FGFR mutation
Urothelial Cancer
erdafitinib + JNJ-63723283
Sensitive: C3 – Early Trials
FGFR mutation
Urothelial Cancer
FGFR inhibitor
Sensitive: C3 – Early Trials
FGFR mutation
Solid Tumor
ICP-192
Sensitive: C3 – Early Trials
FGFR mutation
Cholangiocarcinoma
ponatinib
Sensitive: C3 – Early Trials
FGFR mutation
Cholangiocarcinoma
pemigatinib
Sensitive: C3 – Early Trials
FGFR mutation
NSCLC
pemigatinib
Sensitive: C3 – Early Trials
FGFR mutation
Astrocytoma
pemigatinib
Sensitive: C3 – Early Trials
FGFR mutation
Uterine Cancer
pemigatinib
Sensitive: C3 – Early Trials
FGFR mutation
Gallbladder Cancer
pemigatinib
Sensitive: C3 – Early Trials
FGFR mutation
Head and Neck Cancer
pemigatinib
Sensitive: C3 – Early Trials
FGFR mutation
Breast Cancer
E7090
Sensitive: D – Preclinical